GSC The List

Post Reply
Forum Home > A > ALZHEIMER'S DISEASE*+ [2013-2015]

[email protected]
Site Owner
Posts: 1174

Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (full – 2013)

The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full – 2013)

R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease (full – 2013)

Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF– 2013)

Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice. (link to PDF– 2013)

Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst – 2013)

CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients (abst – 2013)

CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice (abst – 2013)

Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease. (abst – 2013)

Implication of JNK pathway on tau pathology and cognitive decline in a senescence accelerated mouse model (abst – 2013)

Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013)

Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier (abst – 2013)

Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst – 2013)

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst – 2013)

Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013)

In vivo type 1 cannabinoid receptor availability in Alzheimer's disease (abst – 2013)

Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst – 2013)

Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease (abst – 2013)

Medical marijuana helps senior sleep, contend with other problems of aging (news – 2013)

Terpenes May Improve Effectiveness Of Medical Marijuana (news – 2013)

Still Believe Nature Got It Wrong? Top 10 Health Benefits of Marijuana (news – 2013)

Marijuana may improve stamina, rejuvenate brain —study (news – 2013)

New Study Shows Cannabinoids Improve Efficiency Of Mitochondria And Remove Damaged Brain Cells (news – 2013)

Cannabis may help reverse dementia: study (news – 2013)

Marijuana's Memory Paradox (news/ forum repost – 2013)

New Study Finds Marijuana Could Help Treat Alzheimer’s Disease (news – 2013)

Marijuana cannabinoids slow brain degradation and aging, reverse dementia: here's how (news – 2013)

Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic (full– 2014)

The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease? (full – 2014)

Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer's disorders using molecular docking and molecular dynamics simulation. (full – 2014)

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease (full – 2014)

c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo (full – 2014)

The endocannabinoid system: a putative role in neurodegenerative diseases (full – 2014)

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF – 2014)

Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease (abst – 2014)

Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions (abst – 2014)

β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (abst – 2014)

Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression (abst – 2014)

Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst – 2014)

Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst – 2014)

The Potential Therapeutic Effects of THC on Alzheimer's Disease (abst – 2014) 83&pi=8

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease (abst – 2014)

Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease (abst – 2014)

Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms (abst – 2014)

Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression (abst – 2014)

Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease (abst – 2014)

β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst – 2014)

Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer's Disease (abst – 2014)

Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst – 2014)

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease (abst – 2014)

Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation (abst – 2014)

Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (abst – 2014)

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst – 2014)

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice (abst – 2014)

Blocking brain's 'internal marijuana' may trigger early Alzheimer's deficits, study shows (news – 2014)

"Brain Marijuana" Can Help with Dementia (news – 2014)

Marijuana compound may offer treatment for Alzheimer's disease (news – 2014)

Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst – 2015)

N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst – 2015)

How Medical Marijuana’s Chemicals May Protect Cells (news – 2015)

March 11, 2015 at 8:00 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.